Sanofi is ending a Phase 2 clinical trial that’s testing a drug from Denali for multiple sclerosis, putting a stop to the development plan. … ...
Cambridge, MA, October 28, 2024 –Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence ...
Sanofi expects a low single-digit decline in flu shot sales due to the soft vaccination rate. Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company ...
Lipoproteins are composed of a combination of lipid (fat) and protein. They have important roles in transporting cholesterol and triglycerides to throughout the body. A standard lipid profile blood ...
Sanofi is aiming to sign an agreement this weekend to sell control of its consumer health business to Clayton Dubilier & Rice, following a last-ditch attempt by a rival bidder to derail the deal ...
The new entity focuses on the discovery, design and development of RLTs. Credit: PeopleImages.com – Yuri A/Shutterstock. Sanofi and Orano Group subsidiary Orano Med have announced a partnership to ...
The buyout firm improves its bid by about €200 million CD&R still aims to sign a deal as soon as the coming days PAI Partners has submitted an improved offer for Sanofi ’s consumer health business, ...
A consortium including French private equity firm PAI Partners has raised its offer for Sanofi's consumer health business, Opella, according to sources. The group has revised its bid by €200m ...
Sanofi pitched today’s announcement in the context of its move last month to pay Orano Med and its partner RadioMedix 100 million euros upfront and commit up to 220 million euros in sales ...
Sanofi Romania has appointed Buğra Kulak as Head of Pharma and Country Lead of Sanofi Romania. He succeeds Dr. Iulia Ionescu, whose term concluded after four years of leading the Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback